The report is available in English with a French summary - KCE

More documents

Recommendations

Info

24 Musculoskeletal & Neurological Rehabilitation KCE reports 57 2.2.2.1 Stroke INCIDENCE For Belgium, crude incidence data for stroke (first ever AND recurrent) vary from 200 to 230 per 100 000 inhabitants per year 26, 27 . After age adjustment more males (196 per 100 000) than females (163 per 100 000) are affected by stroke (first ever AND recurrent) 28 . Age and gender adjusted incidence for stroke (first ever AND recurrent) is situated around 185 per 100 000 inhabitants per year 29, 30 . In a recent (2006) review using the structure of WHO’s stroke component of the WHO InfoBase, studies on stroke epidemiology published in peer-reviewed journals were analysed. It concerned 44 incidence studies and 12 prevalence studies. Data for Belgium are presented in Figure 2.4. 31 Figure 2.4: Stroke incidence estimates for Belgium 31 Age Belgium Men Women 25–34 19 12 35–44 37 23 45–54 139 84 55–64 312 186 65–74 812 550 75–84 1446 1237 85+ 1754 1661 Internationally, crude incidence for stroke (first ever AND recurrent) ranges from 174 to 224 per 100 000 inhabitants per year 32, 33 . Crude incidence for first ever stroke is situated around 280 per 100 000 inhabitants per year 32 , 34, 35 , that is a large number compared to the other data obtained and as a consequence to consider with reserves. And, as in Belgium, more males (280 per 100.000) than females (200 per 100 000) were affected 36 . Age adjusted incidence for stroke (first ever AND recurrent) ranges from 101 to 285 per 100 000 inhabitants per year for males and from 47 to 198 per 100 000 inhabitants per year for females 37 . Age adjusted incidence for first ever stroke ranges from 100.4 to 182 per 100 000 inhabitants per year 38, 33, 39-41 . Age and gender adjusted incidence for stroke (first ever AND recurrent) ranges from 220 to 269 per 100 000 42, 43 . Age and gender adjusted incidence for first ever stroke ranges 33, 42, 35 from 161 to 208 per 100.000 inhabitants per year
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 25 PREVALENCE Belgian data on stroke prevalence were obtained via a recent review using the structure of WHO’s stroke component of the WHO InfoBase. Studies on stroke epidemiology published in peer-reviewed journals were analysed. It concerned 44 incidence studies and 12 prevalence studies. See Figure 2.5. 31 Figure 2.5: Stroke prevalence rates for Belgium 31 Age Belgium Men Women 25–34 114 65 35–44 218 124 45–54 1072 804 55–64 2185 1476 65–74 5052 3568 75–84 7830 6260 85+ 9403 8362 Internationally, large differences in prevalence data of stroke appeared. In one publication the prevalence of stroke was estimated at 750 per 100 000 43 . In another publication the prevalence was estimated about 100 per 100 000 44 what is probably an underestimation in comparison with the incidence data. MEAN AGE AND MORTALITY The mean age at onset for males is 63.3 years, for females 71.4 years 36 . Yearly stroke 45, 33 , 41 , mortality ranges at 28 days from 15.9% to 33% and at 1 year from 26.3% to 37.3% 35 . 2.2.2.2 Total Hip Replacement INCIDENCE The crude incidence of total hip replacement in Belgium was about 160 per 100 000 inhabitants in 2004 46 . Internationally, the crude incidence of total hip replacement ranges from 58 to 126 per 100 000 47, 48 . Age standardized incidence of total hip replacement (primary and revision) ranges from 112 to 113 per 100 000 49 . Age standardized incidence of primary hip replacement show a higher incidence for females (87.1 per 100 000) then for males (65.5 per 100 000 50 . The same counts for the hip revisions (females: 21.0 per 100 000; Males: 16.6 per 100 000) 51 . Age and gender standardised incidence of primary hip replacement ranges from 134 to 193 per 100 000, of revisions from 21.1 to 43 per 100 000 52 , 53 . In 2004, 16 599 THR were registered in Belgium 46 . PREVALENCE An estimation of the prevalence of hip disease severe enough to require surgery was 1520 per 100 000 aged 35-85 54 MEAN AGE AND MORTALITY The mean age of the population undergoing a primary hip replacement is 68.6 years and 71.8 years within the population undergoing a revision 51
Page 1 and 2: Organisation et Financement de la R
Page 3 and 4: Organisation et financement de la r
Page 5 and 6: KCE Reports 57B Réadaptation locom
Page 15 and 16: KCE Reports 57 Musculoskeletal & Ne
Page 21 and 22: KCE reports 57 Musculoskeletal & Ne
Page 37: KCE reports 57 Musculoskeletal & Ne
Page 89 and 90:
KCE reports 57 Musculoskeletal & Ne
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
KCE Reporst 57 Musculoskeletal & Ne
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
KCE Reports 57 Musculoskeletal & Ne
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291:
Page 294 and 295:
Dépôt légal : D/2007/10.273/19
Page 296:
35. Etude relative aux coûts poten
show all

The report is available in English with a French summary - KCE

Create successful ePaper yourself

Delete template?

Save as template?